missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Novus Biologicals™ Siglec-2/CD22 Antibody (epratuzumab) - Humanized, IgG4SP, Novus Biologicals™
Human Monoclonal Antibody
Brand: Novus Biologicals™ NBP3-28019-50ug
This item is not returnable.
View return policy
Description
Siglec-2/CD22 Monoclonal antibody specifically detects Siglec-2/CD22 in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay
Specifications
| Siglec-2/CD22 | |
| Monoclonal | |
| Unconjugated | |
| P20273 | |
| Human | |
| Protein A purified | |
| RUO | |
| Primary | |
| Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex. | |
| Store at -20°C in powder form. Store at -80°C once reconstituted. | |
| IgG4 |
| Flow Cytometry, ELISA, Functional Assay | |
| epratuzumab | |
| Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2) | |
| B-cell receptor CD22, BL-CAM, B-lymphocyte cell adhesion molecule, CD22 antigenMGC130020, CD22 molecule, sialic acid binding Ig-like lectin 2, Sialic acid-binding Ig-like lectin 2, SIGLEC-2, SIGLEC2FLJ22814, T-cell surface antigen Leu-14 | |
| Siglec-2/ CD22 | |
| 50 μg | |
| Adaptive Immunity, B Cell Development and Differentiation Markers, DNA Repair, Immunology, Phospho Specific | |
| 933 | |
| Human | |
| Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction